Full View

Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3

K Zhang, Y Dong, M Li, W Zhang, Y Ding… - Cancer …, 2023 - Wiley Online Library
Colorectal cancer (CRC) is related to gut microbiota dysbiosis, especially butyrate‐
producing bacteria reduction. Our previous study suggested that administration of …
被引用次数：5 相关文章

Clostridium butyricum inhibits epithelial-mesenchymal transition of intestinal carcinogenesis through downregulating METTL3.

K Zhang, Y Dong, M Li, W Zhang, Y Ding, X Wang… - Cancer …, 2023 - europepmc.org
Colorectal cancer (CRC) is related to gut microbiota dysbiosis, especially butyrate-
producing bacteria reduction. Our previous study suggested that administration of …

Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3

K Zhang, Y Dong, M Li, W Zhang, Y Ding… - Cancer …, 2023 - search.proquest.com
Colorectal cancer (CRC) is related to gut microbiota dysbiosis, especially butyrate-
producing bacteria reduction. Our previous study suggested that administration of …
[HTML] nih.gov

[HTML][HTML] Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3

K Zhang, Y Dong, M Li, W Zhang, Y Ding, X Wang… - Cancer …, 2023 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is related to gut microbiota dysbiosis, especially butyrate‐
producing bacteria reduction. Our previous study suggested that administration of …

Clostridium butyricum inhibits epithelial-mesenchymal transition of intestinal carcinogenesis through downregulating METTL3

K Zhang, Y Dong, M Li, W Zhang, Y Ding… - Cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is related to gut microbiota dysbiosis, especially butyrate-
producing bacteria reduction. Our previous study suggested that administration of …